ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

FDBK Feedback Plc

60.50
0.00 (0.00%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 60.50 60.00 61.00 60.50 60.50 60.50 14,770 07:44:37
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -2.77 8.07M
Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 60.50p. Over the last year, Feedback shares have traded in a share price range of 58.00p to 150.00p.

Feedback currently has 13,334,659 shares in issue. The market capitalisation of Feedback is £8.07 million. Feedback has a price to earnings ratio (PE ratio) of -2.77.

Feedback Share Discussion Threads

Showing 8776 to 8800 of 14875 messages
Chat Pages: Latest  355  354  353  352  351  350  349  348  347  346  345  344  Older
DateSubjectAuthorDiscuss
06/5/2020
18:23
Sonie, it was late in the briefing, the Lady called Nickie, I think, referring to the retired clinicians who have returned to the NHS to help. She said she hoped they would stay and be able work differently, maybe digitally. I thought that was interesting!!!
ducatiman
06/5/2020
18:16
I missed it dc, what did they say?
sonie01
06/5/2020
18:00
I hope everyone was listening very carefully to today’s Govt covid briefing.
ducatiman
06/5/2020
14:54
Sorry for off topic again but this shows how corrupt the markets can be and/or how stupid some folk can be.

I just checked the toplist. At the top was MLVN 100% gain today.
Checked announcements. Last RNS:-

It is currently anticipated that the Company's existing working capital facilities will be exhausted by the end of May. The Company is in discussion with its existing major shareholders and debt providers regarding the raising of additional funding.

Either a leak about funding or just crazy traders!

I'm going to put my Dahlias in or I'll go mad!

ged5
06/5/2020
14:19
There isn't one reference to clinical grade images in that article but using Unison seems like good marketing.

From the 20th April RNS:

Bleepa ® is a secure image-based communication platform which provides access
to clinical grade medical images and facilitates instant messaging based case discussion through a zero footprint application. Bleepa ® can be accessed from any internet connected device including phones, tablets, laptops and desktops; clinicians can use their own devices and therefore no additional hardware is required.

Any medical imaging investigation can be seamlessly shared through Bleepa ® to the entire clinical team, even if those teams are geographically separated or having to work remotely. Cases can be discussed through secure instant messaging and
image annotation, allowing comments and decisions to be communicated instantly between team members. Importantly, during the outbreak, Bleepa ® can enable case review by clinicians at other hospitals where multisite communication is needed.

Home-based image review and case discussion at this scale requires a new infrastructure and a secure bespoke imaging solution which is capable of scaling to meet these demands. Bleepa ® is designed for exactly this purpose and overcomes the problems associated with trying to scale traditional VPN-based remote access solutions to hospital software.

ged5
06/5/2020
13:55
I think it was LR2 who suggested that FDBK should buy out Hospify so they would have a larger foothold in the NHS.

Thanks for your link to the article. I get the feeling that Tom Oakley is getting frustrated with the time it's taking to convince more trusts to trial what he and others believe to be an excellent imaging/messaging tool for front line clinicians.

ged5
06/5/2020
13:50
I can't disagree with any of that Meganxmas.

Hi Orange1,

Hospify was discussed earlier on the thread.

Bleepa's USP is the only messaging device which can show clinical grade images that can be annotated.

ged5
06/5/2020
13:35
What do people here think about the following:

1. Competition

There are many healthcare messaging apps on the market. Some like Hospify seem to have a bigger footprint than Bleepa at the moment. They are for example in the NHS App library.

Does Bleepa have a USP?

2. The healthcare market is highly fragmented.

This is a quote from an article on Hospify:

“A factor that most people don’t understand about the NHS is that it’s not one entity,” said Flint. “It’s not a case of just selling to the Department of Health and then you’ve got access to a massive market. That’s not how it works. It’s not one organisation, it’s an industry. It has 10,000 organisations within it. There are 2,500 hospitals, and 7,500 GP surgeries, and every single one is a separate business, with its own P&L and each one is acts independently from the Department of Health and makes its own decisions. This is one of the reasons why investors aren’t that crazy about the healthcare sector.”

orange1
06/5/2020
12:59
This share is pretty illiquid and so susceptible to speculation good or bad. Results will come out and they will be pretty bland and in line with what everyone knows. The value of the company and the price of shares will rise exponentially if and when Bleepa is successful. Until that point the price will remain in a range that isn't very inspiring and with large spreads ... might spike up but if on Twitter speculation then will only come back down again. Trading opportunities at meaningful levels are few and far between. So I'm afraid is a waiting game and yes I would like to see the CE mark as well. Bought in for Bleepa and see no reason to change that stance.
meganxmas
06/5/2020
12:36
The share price is not a pretty sight and the notified spread is awful.

Year end in just under four weeks. Can we expect a trading update?

2018 Trading update 3rd October 2018 Results 29th November 2018
2019 Trading update 25th April 2019 Results 24th October 2019

So we could get a trading update any time from now upto November.
Results are 'imminent'

ged5
06/5/2020
11:04
We can get excited today about the sticker! ;))
ged5
06/5/2020
09:10
....and the man in charge using ‘imminent̵7; over five weeks ago!
zooskeeper
06/5/2020
08:50
Hardly surprising the volatility with by how excited some were getting about 3 lines of text in an AWS daily newsletter
lukehold
05/5/2020
22:16
Me too yump, came in when they were suppose to be getting FDA approval, never transpired, had management changes and the business has changed direction, thought the appt of TO was a very good one as he is well networked within the NHS, it is time we got some good news for the share price to move north. I think the market is also slightly weary with what has gone off in the past ie not delivering on promises, time it does or I fear the worst. Great that we have got Bleepa in NHS even tho it's free for now, hopefully will gain traction in the NHS so it can be monetised
sonie01
05/5/2020
21:23
Set a top up at 0.86
lukehold
05/5/2020
20:33
Oh sorry got used to people wanting a rise just after they’ve invested. I’m an outsider in some ways - only bought because of Bleepa so hope ‘this time its different’ !
yump
05/5/2020
16:56
I am an investor yump, been in feedback for nearly 2 years now
sonie01
05/5/2020
15:15
There’s been plenty of chance to trade this the last couple of weeks if you want to churn between 2-500k on 10-20%, just depends how greedy you are, whether you have a decent broker that doesn’t rip you off and whether you can bothered.
riggerbeautz
05/5/2020
14:08
When you become an investor, not a trader.
yump
05/5/2020
12:54
FFS when will this come good?
sonie01
05/5/2020
10:51
Reading an article about "What have the NHSX been up to" I was a little disappointed to read:-

The NHSX are shifting the funding initially intended to give the frontline digitisation from the GDE programme to a new digital aspirant programme.

Am I right in thinking Bleepa is more frontline digitisation rather than a new digital aspirant programme or could it be considered as both?

However the last sentence may give some hope!:-

Soon a Tech Plan will be introduced that will set out the NHSX’s plans in more detail and demonstrate how tech will help deliver the NHS Long Term Plan.

I'll be looking out for this Long Term Plan.



I see Dr Gareth Thomas is leading Digital Responses Webinar today at 12:30.
Dr. Thomas is from Salford Royal so I presume he's heard about Bleepa. I wonder if Tom Oakley has registered.

ged5
05/5/2020
10:25
holding now more steady currently after drop
bunz3
04/5/2020
19:06
https://twitter.com/Hospital_Times/status/1257232011426762753?s=19Digital tech in healthcare: Is this a time for change?Hospital Times 4th May 2020 Digital tech in healthcare: Is this a time for change?2020-05-04T09:45:05+01:00Clinical ServicesCovid-19 is accelerating the adoption of digital technology across the health sector. Dr Tom Oakley, CEO of Feedback Medical, stresses how the NHS should not miss the opportunity to rapidly adopt innovative remote working tools, particularly for diagnostics.
meganxmas
04/5/2020
14:40
Didn't think they would walk it down to below one pee 😒
digger2779
04/5/2020
14:39
Dealing with the NHS is difficult its so 'layered' i wonder how much a single Ham sanwhich would cost once it get to the patient . some estimate is £50 !
pal44
Chat Pages: Latest  355  354  353  352  351  350  349  348  347  346  345  344  Older

Your Recent History

Delayed Upgrade Clock